The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic, Inc. BioZorb marker due to complications with implanted devices. The agency identified this as a Class I recall, the most serious type of recall. Details issued in a written notice by the FDA on May 22 and are shared here.
The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's devices that are implanted in soft tissue such as breast tissue as "most serious", and.
The U.S. Food and Drug Administration
on Wednesday classified a recall of Hologic s devices
that are implanted in soft tissue such as breast tissue as most
serious, and urged doctors to more actively.